JP2015517577A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517577A5
JP2015517577A5 JP2015514140A JP2015514140A JP2015517577A5 JP 2015517577 A5 JP2015517577 A5 JP 2015517577A5 JP 2015514140 A JP2015514140 A JP 2015514140A JP 2015514140 A JP2015514140 A JP 2015514140A JP 2015517577 A5 JP2015517577 A5 JP 2015517577A5
Authority
JP
Japan
Prior art keywords
aryl
het
nhr
cycloalkyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015514140A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517577A (ja
JP6653573B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/042148 external-priority patent/WO2013177241A1/en
Publication of JP2015517577A publication Critical patent/JP2015517577A/ja
Publication of JP2015517577A5 publication Critical patent/JP2015517577A5/ja
Application granted granted Critical
Publication of JP6653573B2 publication Critical patent/JP6653573B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015514140A 2012-05-22 2013-05-22 シクロアルカニル［ｂ］インドール、シクロアルカニル［ｂ］ベンゾフラン、シクロアルカニル［ｂ］ベンゾチオフェンを合成するための方法、化合物および使用の方法 Active JP6653573B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261650039P 2012-05-22 2012-05-22
US61/650,039 2012-05-22
US201361757876P 2013-01-29 2013-01-29
US61/757,876 2013-01-29
PCT/US2013/042148 WO2013177241A1 (en) 2012-05-22 2013-05-22 Method for synthesizing cycloalkanyl(b}indoles, cycloalkanyl(b) benzofurans, cycloalkanyl(b)benzothiophenes, compounds and methods of use

Publications (3)

Publication Number Publication Date
JP2015517577A JP2015517577A (ja) 2015-06-22
JP2015517577A5 true JP2015517577A5 (enExample) 2016-07-07
JP6653573B2 JP6653573B2 (ja) 2020-02-26

Family

ID=49624309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015514140A Active JP6653573B2 (ja) 2012-05-22 2013-05-22 シクロアルカニル［ｂ］インドール、シクロアルカニル［ｂ］ベンゾフラン、シクロアルカニル［ｂ］ベンゾチオフェンを合成するための方法、化合物および使用の方法

Country Status (4)

Country Link
US (1) US9598365B2 (enExample)
EP (1) EP2887804B1 (enExample)
JP (1) JP6653573B2 (enExample)
WO (1) WO2013177241A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2968884A1 (en) 2014-12-10 2016-06-16 Massachusetts Institute Of Technology Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
US10526287B2 (en) 2015-04-23 2020-01-07 Constellation Pharmaceuticals, Inc. LSD1 inhibitors and uses thereof
MX391259B (es) 2015-10-14 2025-03-21 X Therma Inc Composiciones y métodos para reducir la formación de cristales de hielo.
CN109071456A (zh) 2016-02-16 2018-12-21 麻省理工学院 作为myc调节剂的max结合剂及其用途
AU2017348100B2 (en) 2016-10-26 2021-08-26 Constellation Pharmaceuticals, Inc. LSD1 inhibitors and medical uses thereof
US11633379B2 (en) 2017-01-04 2023-04-25 Trustees Of Dartmouth College Methods of inhibiting PCSK9
MX2023000036A (es) * 2020-06-27 2023-02-01 Crescenta Biosciences Composicion de compuestos que modulan el metabolismo celular y metodos de uso.
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds
CN120590310B (zh) * 2025-08-07 2025-10-28 昆明医科大学 一种吲哚-3-芳基酮衍生物及其制备方法和应用
CN121102205B (zh) * 2025-11-17 2026-02-17 昆明医科大学 一种吲哚-3-芳基酮衍生物在制备治疗或预防金黄色葡萄球菌引起的感染性疾病的药物中的用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3696118A (en) * 1970-04-22 1972-10-03 Marcel K Eberle SPIRO NORBORNANE 6,9-METHANOCYCLOHEPT(b)INDOLES
US3931288A (en) * 1972-03-13 1976-01-06 Hoffmann-La Roche Inc. Alkyl esters of 4-chlorophenoxy-4-oxo-cycloalkyl-carboxylic acid
US4755505A (en) * 1987-08-18 1988-07-05 American Home Products Corporation 1-[2-(dialkylamino)alkyl]-4,5-dihydro-4-(aryl)-1-benzazocine-2,6(1H,3H)-diones as anti-arrhythmic agents
AU3840000A (en) 1999-04-20 2000-11-02 Meiji Seika Kaisha Ltd. Tricyclic compounds
ATE280170T1 (de) * 2000-11-03 2004-11-15 Wyeth Corp Cyclopenta(b)(1,4) diazepino(6,7,1-hi)indole als 5ht2c antagonisten
TW200307540A (en) 2002-04-25 2003-12-16 Wyeth Corp [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
JP4484108B2 (ja) 2002-05-16 2010-06-16 塩野義製薬株式会社 Ｐｇｄ２受容体拮抗作用を有する化合物
WO2004063156A1 (en) * 2003-01-08 2004-07-29 Biovitrum Ab Novel indole derivates as fabp-4 inhibitors
WO2004069831A1 (en) * 2003-02-10 2004-08-19 Glenmark Pharmaceuticals Ltd. Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation
WO2004110999A1 (en) 2003-06-10 2004-12-23 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
US7622494B2 (en) 2003-08-26 2009-11-24 Smithkline Beecham Corporation Chemical compounds
WO2005094833A1 (en) 2004-03-31 2005-10-13 Council Of Scientific And Industrial Research Novel n-substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
ES2446044T3 (es) 2004-09-20 2014-03-06 Janssen Pharmaceutica Nv Derivados tetracíclicos novedosos que contienen heteroátomos útiles como moduladores de los receptores de hormonas sexuales esteroideas
US7338973B2 (en) 2004-09-20 2008-03-04 Janssen Pharmaceutica N.V. Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
RS52642B (sr) 2004-11-18 2013-06-28 Synta Pharmaceuticals Corp. Jedinjenja triazola koja modulišu aktivnost hsp90
WO2006121466A2 (en) 2004-11-22 2006-11-16 Smithkline Beecham Corporation Hcv inhibitors
WO2006121467A2 (en) 2004-11-22 2006-11-16 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives for treating flaviridae viruses
CA2619276A1 (en) 2005-08-12 2007-02-22 Genentech, Inc. Pentacyclic kinase inhibitors
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
AU2007284537B2 (en) 2006-08-17 2012-04-12 Synta Pharmaceuticals Corp. Triazole compounds that modulate HSP90 activity
CL2009000725A1 (es) 2008-03-24 2009-05-29 Medivation Technologies Inc Compuestos derivados de heterociclos con uniones puente sustituidos, moduladores de receptores adrenergicos, de serotonina, de dopamina y de histaminas; composicion farmaceutica; kit farmaceutico; y su uso en el tratamiento del trastorno cognitivo y trastorno psicotico.
WO2010036998A2 (en) 2008-09-29 2010-04-01 Abbott Laboratories Indole and indoline derivatives and methods of use thereof
WO2010054382A1 (en) 2008-11-10 2010-05-14 Elixir Pharmaceuticals, Inc. Compounds, compositions, and methods for treating malaria or leishmaniasis
JP5497284B2 (ja) * 2008-12-08 2014-05-21 ユー・ディー・シー アイルランド リミテッド 白色有機電界発光素子
NZ595410A (en) 2009-03-27 2013-12-20 Merck Sharp & Dohme Inhibitors of hepatitis c virus replication
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
US8575186B2 (en) 2009-10-05 2013-11-05 Albany Molecular Research, Inc. Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
US8778959B2 (en) 2009-12-17 2014-07-15 Abbvie Inc. AZA-bridged ring-fused indoles and indolines
GB201016411D0 (en) * 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
WO2012054526A2 (en) * 2010-10-19 2012-04-26 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies

Similar Documents

Publication Publication Date Title
JP2015517577A5 (enExample)
JP5701608B2 (ja) 有機化合物
EP2344460B1 (en) Novel imidazolidine compounds as androgen receptor modulators
JP5260489B2 (ja) ベンズイミダゾール誘導体、及びｇａｂａａ受容体複合体をモジュレートするためのその使用
AU2016245278B2 (en) Process for the preparation of androgen receptor antagonists and intermediates thereof
JP2020517707A5 (enExample)
JP2017515901A5 (enExample)
JP2015181191A5 (enExample)
EP2960234A1 (en) Trk-INHIBITING COMPOUND
JP2010513494A5 (enExample)
AR074676A1 (es) Derivados de isooxazol como antagonistas de receptores de acido lisofosfatidico, composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por la actividad fisiologica de lpa.
JP2020532550A (ja) リゾホスファチジン酸受容体１（ｌｐａｒ１）阻害剤化合物
RU2644766C2 (ru) Способ получения 4-[5-(пиридин-4-ил)-1н-1,2,4-триазол-3-ил]пиридин-2-карбонитрила и его промежуточное соединение
Zhou et al. Nucleophilic addition of tertiary propargylic amines to arynes followed by a [2, 3]-sigmatropic rearrangement
TR201802981T4 (tr) Florofenil pirazol bileşikleri.
TW200526646A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2018523644A5 (enExample)
JP2018505179A5 (enExample)
TW200526592A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
Wang et al. Synthesis, Characterization, and Reactivity of N-Acyl Chloroformamidines: Useful Building Blocks for the Construction of N-Acyl-Substituted 1, 1-Diaminoethylenes, Amidines, Ureas, and Thioureas
CN105130915A (zh) 一种制备胺基取代的三唑衍生物的方法
JP2012516899A5 (enExample)
JPWO2009048123A1 (ja) ビス（トリメチルシリル）フェニル化合物又はその塩、及びその用途
JP2006176509A5 (enExample)
CN105693617B (zh) 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法